Adaptive Biotechnologies (ADPT) Depreciation and Depletion (2018 - 2026)

Adaptive Biotechnologies (ADPT) has 9 years of Depreciation and Depletion data on file, last reported at $3.4 million in Q1 2026.

• Quarterly Depreciation and Depletion fell 20.73% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.2 million (down 10.94% YoY) and the FY2025 annual result came in at $16.1 million, down 8.28% from the prior year.
• Depreciation and Depletion declined to $3.4 million in Q1 2026 per ADPT's latest filing, from $3.7 million in the prior quarter.
• The five-year high for Depreciation and Depletion was $5.3 million in Q3 2023, with the low at $3.4 million in Q1 2026.
• Average Depreciation and Depletion over 5 years is $4.5 million, with a median of $4.6 million recorded in 2022.
• Year-over-year, Depreciation and Depletion jumped 105.91% in 2022 and dropped 21.97% in 2024.
• Adaptive Biotechnologies' Depreciation and Depletion stood at $4.9 million in 2022, then increased by 2.18% to $5.0 million in 2023, then dropped by 19.0% to $4.0 million in 2024, then fell by 7.16% to $3.7 million in 2025, then dropped by 8.41% to $3.4 million in 2026.
• Business Quant data shows ADPT's Depreciation and Depletion at $3.4 million in Q1 2026, $3.7 million in Q4 2025, and $4.0 million in Q3 2025.